SEC Form 4 · accession 0001209191-17-051780
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Helen Louise Collins
Officer — SVP and Chief Medical Officer
Period of report
Sep 1, 2017
Accepted (ET)
Sep 6, 2017 · 7:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 1, 2017 | F | 376 | $34.34 | D | 24,780 | D |
Table II — derivative securities
No Table II lines on this filing.